AUDUSD is above the descending channel between the trend lines. The price has already consolidated above the descending channel and is now moving from the dynamic resistance. The chart is approaching the dynamic support, which previously acted as a growth point. We expect the growth to continue after the retest of the lower trend line. ------------------- Share your opinion in the comments and support the idea with like. Thanks for your support!
Or is it just another stock whose value will be wiped out in the next few quarters, and the company will simply lose its listing on the Nasdaq? Investors are likely to get an answer to this question today, before the market opens, when NASDAQ:GERN reports its quarterly earnings. The company has an approved drug and has already begun commercialization, with a promising start. Last quarter, the company generated $28 million in revenue, and this quarter, revenue is expected to reach $61.8 million. The company has already achieved positive gross margins, and I expect them to improve significantly from the current 27% in the last quarter. Operating expenses are close to $30 million per quarter, so we can expect a quick path to operating profitability. Invested capital is around $135 million, which means that with an operating profit of $10 million per quarter, we could see interesting returns on invested capital. The company is led by John A. Scarlett, M.D., who previously worked at NASDAQ:CTMX for six years, during which the company lost about 90% of its value. There is some positive news regarding European approval: "The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion." A decision is expected in the coming months, if not days, which should serve as a strong catalyst for the stock price. The market valuation has dropped to $1.4 billion, despite having an FDA-approved drug in the U.S. Cash reserves will be important as they indicate how much time the company has to develop without diluting its capital. In the last report, cash and short-term investments totaled $339 million, and on November 7, the company announced securing $250 million in funding, with the potential to increase it to $375 million. As a result, the company has $589 million in cash reserves minus operating cash flow. How much will remain in the coffers? The company should have enough cash for more than 12 months of successful operations, operational efficiency is improving, we are awaiting European approval, and only the quality of management raises doubts. But do these doubts really hold weight given the current trajectory? There are only a few hours left until the earnings report is released. Let's see what awaits us. Strong Holders Profiting From Strength ?✊?
Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst. ?LINK has been in a correction phase trading within the falling blue channel and it is currently retesting the lower bound of it. Moreover, the blue zone is a strong structure and round number $15. ? Thus, the highlighted blue circle is a strong area to look for buy setups as it is the intersection of structure and lower orange trendline acting as a non-horizontal support. ? As per my trading style: As #LINK approaches the blue circle, I will be looking for bullish reversal setups (like a double bottom pattern, trendline break , and so on...) ? Always follow your trading plan regarding entry, risk management, and trade management. Good luck! All Strategies Are Good; If Managed Properly! ~Rich
Looking at placing Longs in 74k region. Cumulative support at this price including: 0.382 Fib from cycle Low to current top. Diagonal Up-Ward Trend resistance. Horizontal Break-Out resistance. Would expect big buyer liquidity in this region for a minimum a strong bounce higher or the upward trend to resume. Alarms set
The price is consolidating near 13.00, a key support level. Historical rejection at this zone suggests buyers are stepping in, indicating a potential reversal. A sustained move above 13.00 (previous resistance-turned-support) signals bullish momentum. Traders may anticipate a rally toward higher timeframe resistance levels. Entry Stop Loss And Target Profit are mentioned
From the 4-hour analysis, the upper short-term resistance is around 2936-40. The intraday rebound relies on this position to continue to be short and follow the trend to fall. The lower target is to focus on the stabilization of the support at the 2910 mark. The short-term watershed between long and short strength is 2900. The daily level holds this position and continues to see a wide range of long and short shocks. In the middle position, watch more and move less, be cautious in chasing orders, and wait patiently for key points to enter the market. I will remind you of the specific operation strategy during the session, and pay attention to it in time. Operation strategy: 1. Go long at 2908-2912, go long at 2900, target 2935-2940, and continue to hold after a breakthrough 2. Go short at 2936-2940, target 2910-2915
XAUUS Selling opportunity Selling opportunity Appears in H4 Time Frame Looking Price Action for Long Term Sell "DISCLAIMER" Trading & investing business is "Very Profitable" as well as risky, so any trading or investment decision should be made after Consultation with Certified & Regulated Investment Advisors, by Carefully Considering your Financial Situation.
Short Term Trading Advice by Naranj Capital Buy Visa Inc. ● Buy Range- 347 - 351 ● Target- 361 - 364 ● StopLoss- 342 ● Potential Return- 3-4% ● Duration- 14-15 Trading Days
Go Macro with Allio and Build a Portfolio That’s Robust enough to be Defensive and Consistent over the Long-term, but also has the Elasticity to be Opportunistic, and Alpha-Generating in the Short-term. The future of investing is macro- where quantitative analysis falls short, qualitative insights reveal crucial truths. This is the philosophy of Joseph Gradante, […]
Summary: India’s 2025 Budget: Tax cuts, ₹11.2T infra boost, US trade shifts & AI bets. EBC Financial Group breaks down key trader impacts. India’s 2025 Budget just dropped, and it’s packed with juicy details that could shake up your portfolio. From tax relief to tech bets, let’s unpack the key moves and what they mean […]